Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

PharmaZell

PharmaZell
1947 FOUNDED
PRIVATE STATUS
101-200 EMPLOYEES
Corporate LATEST DEAL TYPE
5 FINANCING ROUNDS
2 INVESTMENTS
Description

Developer of active pharmaceutical ingredients (API) intended for blue-chip pharmaceutical companies. The company offers a wide range of active pharmaceutical ingredients related services for different phases of the drug development process - both for originators in the pharmaceutical industry and for producers of generic drugs as well. It also provides services for formulation and compiles required regulatory documents for both the originator and generic pharmaceutical industry.

Formerly Known As
ZellBios
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • Rosenheimer Str. 43
  • 83064 Raubling
  • Germany

+49 08035 000

PharmaZell Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore PharmaZell‘s full profile, request access.

Request full access to PitchBook

PharmaZell Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 18-Oct-2011 0000000000 Biotechnology
GEA Pharmaceutical 12-Jul-2007 Buyout/LBO Pharmaceuticals
To view this company’s complete investment and acquisition history, request access »

PharmaZell Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore PharmaZell‘s full profile, request access.

Request full access to PitchBook

PharmaZell Executive Team (6)

Name Title Board
Seat
Contact
Info
Oliver Bolzern Ph.D Chief Executive Officer & Managing Director
Hermann Frings Chief Financial Officer
Kai Donsbach Ph.D Chief Technology Officer
Kurt Mayrhofer Ph.D Chief Compliance Officer

2 Former Executives

You’re viewing 4 of 6 executives. Get the full list »